36国肌少症患病率及个体与国家层面风险因素:基于全国代表性个体数据的汇总分析
36国肌少症患病率范围为2.1%至17.4%,16国超过5.0%、3国超过10.0%;个体层面高龄、男性、低教育、非全职就业、低家庭财富、吸烟、缺乏运动及≥2种慢病与较高风险相关,国家层面人均GDP较高与较低风险相关。
要点
- 36国≥50岁人群肌少症患病率2.1%–17.4%,16国>5.0%、3国>10.0%。
- 个体层面高龄、男性、低教育、未婚、非全职、低财富、吸烟、缺乏运动、≥2种慢病与较高风险相关。
- 国家层面人均GDP较高、性别发展指数较高、劳动力参与率较低与较低肌少症风险相关。
核心结论
- 肌少症患病率在36国间差异较大,中等收入国家比高收入国家更常见,提示个人与情境条件共同塑造该模式。
研究设计与样本
- 肌少症与严重肌少症采用2019年修订的欧洲老年人肌少症工作组(EWGSOP2)标准定义,患病率按各国年龄与性别标准化。
主要发现
- 36国肌少症患病率范围为2.1%至17.4%,其中16国高于5.0%、3国高于10.0%。
- 个体层面较高风险与高龄、男性、较低教育、未婚或非伴侣状态、非全职就业、较低家庭财富、当前吸烟、非近期饮酒、缺乏体力活动及≥2种慢性病相关(如男性:RR=1.47;95%CI:1.32,1.64)。
- 国家层面较高人均GDP、较高性别发展指数及较低劳动力参与率与较低肌少症风险相关(如人均GDP:RR=0.42;95%CI:0.30,0.60)。
关键数值与推荐
- 肌少症与严重肌少症采用2019年修订的EWGSOP2标准定义。
- 患病率按各国内年龄与性别标准化。
临床怎么用
- 在老年医学科评估中,对高龄、男性、低教育、低家庭财富、吸烟、缺乏运动及≥2种慢病者应警惕肌少症。
- 可将国家层面社会经济指标纳入理解肌少症风险的背景,但个体风险评估仍需结合个人特征。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sarcopenia is an age-related condition that contributes to disability and healthcare burden worldwide. Yet cross-national evidence on prevalence and multi-level risk factors is limited. METHODS: We pooled data from 10 nationally representative or population-based ageing studies, including 144 226 adults aged ≥50 years from 36 high- and middle-income countries. Sarcopenia and severe sarcopenia were defined using 2019 revised European Working Group on Sarcopenia in Older People criteria. Prevalence was standardised by age and gender within each country. We examined associations between sarcopenia and individual-level sociodemographic and health characteristics, and country-level socioeconomic indicators. RESULTS: Sarcopenia prevalence ranged from 2.1% to 17.4% across 36 countries, with 16 countries above 5.0% and three above 10.0%. Approximately 92.7 million of 1.07 billion adults ≥50 in these countries were projected to have sarcopenia. At the individual-level, higher risk was associated with older age, gender (men), lower education, being unmarried or not partnered, non-full-time employment, lower household wealth, current smoking, non-recent drinking, physical inactivity and ≥2 chronic diseases (e.g. men: RR = 1.47; 95% CI: 1.32, 1.64). At the country-level, higher gross domestic product (GDP) per capita, higher Gender Development Index and lower Labor Force Participation Rate were associated with lower sarcopenia risk (e.g. GDP per capita: RR = 0.42; 95% CI: 0.30, 0.60). CONCLUSION: Sarcopenia varies widely across countries and is more common in middle-income than high-income settings, pointing to a pattern shaped by both personal and contextual conditions. Addressing the emerging burden of sarcopenia will require integrated strategies targeting modifiable risk factors while tackling contextual and structural inequalities.
引用
- Huang S, Lai W, Flood D, et al. Prevalence of sarcopenia and individual- and country-level risk factors in 36 countries: pooled analysis of nationally representative individual data. Age Ageing. 2026. PMID: 42490599. doi:10.1093/ageing/afag210
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。